Drug Purchasers Defeat Motion To Dismiss In Pay-For-Delay Antitrust Case

Drug Purchasers Defeat Motion To Dismiss In Pay-For-Delay Antitrust Case

CHATTANOOGA, Tenn. - The federal judge in Tennessee overseeing multidistrict litigation involving claims that brand-name pharmaceutical company King Pharmaceuticals LLC and generic drug manufacturer Mutual Pharmaceutical Co. conspired to delay the entry of generic versions of Skelaxin into the market denied the defendants' motion to dismiss on May 20 (In re: Skelaxin $(Metaxalone$) Antitrust Litigation, No. 1:12-md-2343, E.D. Tenn.; 2013 U.S. Dist. LEXIS 70968).

Find full version on lexis Advance®
Access this news story on lexis.com®